XPEL vs. CPRX

Last updated Apr 1, 2026

Compare and contrast key facts about XPEL, Inc. (XPEL) and Catalyst Pharmaceuticals, Inc. (CPRX).

Performance

XPEL vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XPEL, Inc. (XPEL) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

XPEL vs. CPRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XPEL XPEL, Inc.	-11.32%	24.96%	-25.83%	-10.34%	-12.04%	32.43%	251.95%	140.10%	335.82%	0.00%
CPRX Catalyst Pharmaceuticals, Inc.	6.08%	11.84%	24.15%	-9.62%	174.74%	102.69%	-10.93%	95.31%	-50.90%	272.38%

Fundamentals

Market Cap XPEL : $1.23B CPRX : $3.15B
EPS XPEL : $1.85 CPRX : $1.68
PE Ratio XPEL : 23.92 CPRX : 14.71
PEG Ratio XPEL : 1.67 CPRX : 0.26
PS Ratio XPEL : 2.57 CPRX : 5.35
PB Ratio XPEL : 4.30 CPRX : 3.30
Total Revenue (TTM) XPEL : $476.20M CPRX : $588.99M
Gross Profit (TTM) XPEL : $201.02M CPRX : $726.82M
EBITDA (TTM) XPEL : $79.75M CPRX : $257.78M

Returns By Period

In the year-to-date period, XPEL achieves a -11.32% return, which is significantly lower than CPRX's 6.08% return. Over the past 10 years, XPEL has outperformed CPRX with an annualized return of 49.29%, while CPRX has yielded a comparatively lower 35.35% annualized return.

XPEL

• 1D: 10.90%
• 1M: 3.85%
• YTD: -11.32%
• 6M: 33.84%
• 1Y: 50.65%
• 3Y*: -13.32%
• 5Y*: -4.17%
• 10Y*: 49.29%

CPRX

• 1D: 4.12%
• 1M: 7.28%
• YTD: 6.08%
• 6M: 25.69%
• 1Y: 2.10%
• 3Y*: 14.30%
• 5Y*: 40.58%
• 10Y*: 35.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

XPEL vs. CPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPEL

XPEL Risk / Return Rank: 74
XPEL Sharpe Ratio Rank: 77
XPEL Sortino Ratio Rank: 77
XPEL Omega Ratio Rank: 71
XPEL Calmar Ratio Rank: 70
XPEL Martin Ratio Rank: 72

CPRX

CPRX Risk / Return Rank: 41
CPRX Sharpe Ratio Rank: 44
CPRX Sortino Ratio Rank: 38
CPRX Omega Ratio Rank: 37
CPRX Calmar Ratio Rank: 42
CPRX Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XPEL vs. CPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XPEL, Inc. (XPEL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XPEL	CPRX	Difference
Sharpe ratio Return per unit of total volatility	1.11	0.06	+1.05
Sortino ratio Return per unit of downside risk	1.91	0.32	+1.59
Omega ratio Gain probability vs. loss probability	1.22	1.04	+0.18
Calmar ratio Return relative to maximum drawdown	1.36	0.01	+1.35
Martin ratio Return relative to average drawdown	3.73	0.02	+3.71
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XPEL vs. CPRX - Sharpe Ratio Comparison

The current XPEL Sharpe Ratio is 1.11, which is higher than the CPRX Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of XPEL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	XPEL	CPRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.11	0.06	+1.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.08	0.85	-0.92
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.77	0.56	+0.21
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	0.08	0.00

Correlation

The correlation between XPEL and CPRX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

XPEL vs. CPRX - Dividend Comparison

Neither XPEL nor CPRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

XPEL vs. CPRX - Drawdown Comparison

The maximum XPEL drawdown since its inception was -99.77%, which is greater than CPRX's maximum drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for XPEL and CPRX.

Drawdown Indicators

	XPEL	CPRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.77%	-94.25%	-5.52%
Max Drawdown (1Y) Largest decline over 1 year	-31.79%	-27.29%	-4.50%
Max Drawdown (5Y) Largest decline over 5 years	-75.62%	-45.37%	-30.25%
Max Drawdown (10Y) Largest decline over 10 years	-75.62%	-64.87%	-10.75%
Current Drawdown Current decline from peak	-56.35%	-5.89%	-50.46%
Average Drawdown Average peak-to-trough decline	-52.38%	-52.51%	+0.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.61%	15.10%	-3.49%

Volatility

XPEL vs. CPRX - Volatility Comparison

XPEL, Inc. (XPEL) has a higher volatility of 14.09% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 10.39%. This indicates that XPEL's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XPEL	CPRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.09%	10.39%	+3.70%
Volatility (6M) Calculated over the trailing 6-month period	27.25%	23.71%	+3.54%
Volatility (1Y) Calculated over the trailing 1-year period	46.31%	34.96%	+11.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	55.11%	48.24%	+6.87%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.87%	62.81%	+1.06%

Financials